Clinical trial
Study To Investigate Effect Of A New Drug (PF-00446687) In Post-Menopausal Women…
NCT00479570 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00479570 |
|---|---|
| Title | Study To Investigate Effect Of A New Drug (PF-00446687) In Post-Menopausal Women Who Suffer From Sexual Dysfunction. |
| Official title | Phase 2A Multi-Centre, Double Blind, Placebo Controlled 3-Way Cross-Over Study To Investigate The Effect Of Single Doses Of PF-00446687 On Sexual Arousal And Sexual Desire In Women Suffering From Female Sexual Dysfunction (FSD). |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Female Sexual Dysfunction |
| Intervention type | Drug |
| Interventions | PF-00446687, Placebo |
| Enrollment | 23 |
| Start date | Jun 1, 2007 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | May 28, 2007 |
| Last update posted | Jan 31, 2019 |
| Countries | Denmark, Norway, Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: